{
    "id": 19592,
    "cites": 37,
    "cited_by": 0,
    "reference": [
        "Accela Communications website, http://www.accelacommunications.com/PDFs/ACI_eDetail_BestPractices.pdf, Accessed October 29, 2012.",
        "Altonji, J.G., Elder, T.E., and Taber, C.R., \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Selection on observed and unobserved variables: assessing the effectiveness of catholic schools,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Political Economy, 113(1): 151-184, 2005.",
        "Bagwell, K., \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Economic Analysis of Advertising,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d in M. Armstrong and R. Porter, eds., Handbook of Industrial Organization, Volume III (Amsterdam: North-Holland, 2007).",
        "Becker, G.S. and Murphy, K.M., \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093A simple theory of advertising as a good or bad,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Quarterly Journal of Economics, 108:941\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c964, 1993.",
        "Bhattacharya, J. and Vogt, G., \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093A Simple Model of Pharmaceutical Price Dynamics,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The Journal of Law and Economics, 46(2):599\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c626, 2003.",
        "Cameron, C., Trivedi, P., Regression Analysis of Count Data. Cambridge University Press: Cambridge, 1998.",
        "Centers for Medicare and Medicaid Services website, http://www.cms.gov/Research-StatisticsData -and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/index.html, Accessed October 7, 2012.",
        "Chintagunta, P., Goettler, R., and Kim, M., \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093New Drug Diffusion When Forward-Looking Physicians Learn from Patient Feedback and Detailing,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Marketing Research, 49(6): 807-821, 2012.",
        "Dave, D., and Kelly, I., \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Advertising,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d in: Anthony Culyer (Ed.), Encyclopedia of Health Economics, Elsevier Inc., Amsterdam, 2012, Forthcoming.",
        "Dave, D., \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Effects of Pharmaceutical Promotion: A Review and Assessment,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d NBER Working Paper Series No. 18830, National Bureau of Economic Research, Cambridge, MA, February 2013.",
        "Dave, D. and Saffer, D., \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Impact of Direct-to-Consumer Advertising on Pharmaceutical Prices and Demand,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Southern Economic Journal, 79(1): 97-126, 2012.",
        "David, G., Markowitz, S., and Richards-Shubik, S., \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Effects of Pharmaceutical Marketing and Promotion on Adverse Drug Events and Regulation,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d American Economic Journal: Economic Policy, 2(4):1-25, 2010.",
        "Engelberg, J., Parsons, C., and Tefft, N., \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093First, Do No Harm: Financial Conflicts in Medicine,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Working Paper, http://papers.ssrn.com/sol3/papers.cfn?abstract_id=2297094, 2013.",
        "Fugh-Berman, A., and Ahari, S., \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Following the Script: How Drug Reps Make Friends and Influence Doctors,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d PLoS Medicine, 4(4):621-625, 2007.",
        "Gonul, F., Carter, F., Petrova, E., and Srinivasan, K. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Promotion of prescription drugs and its impact on physicians\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2 choice behavior,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Marketing, 65(3): 79-90, 2001.",
        "Grande, D., \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Limiting the Influence of Pharmaceutical Industry Gifts on Physicians: SelfRegulation or Government Intervention,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of General Internal Medicine, 25(1): 79:83, 2010.",
        "Hilltop Institute, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Academic Detailing: A Review of the Literature and States\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2 Approaches,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d University of Maryland-Baltimore County, 2009.",
        "Iizuka, T, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093What explains the use of direct to consumer advertising of prescription drugs?,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Industrial Economics, 52(3):349-379, 2004.",
        "Iizuka, T., and Jin, G.Z, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Effect of Prescription Drug Advertising on Doctor Visits,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Economics and Management Strategy, 14 (3):701-727, 2005.",
        "Iizuka, T., and Jin, G.Z., \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Direct to Consumer Advertising and Prescription Choice,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Industrial Economics, 55 (4):771, 2007.",
        "Kalyanaram, G. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Order of Entry Effect in Prescription (Rx) and Over-the-counter (OTC) Pharmaceutical Drugs,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d International Journal of Pharmaceutical and Healthcare Marketing, 2(1):35-46, 2008.",
        "Kalyanaram, G. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Endogenous Modeling of the Effect of Direct Advertising to Consumers (DTCA) in Prescription Drugs,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d International Journal of Pharmaceutical and Healthcare Marketing, 3(2): 137-148, 2009.",
        "Ling, D.C., Berndt, E.R., and Kyle, M.K. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Deregulating Direct-to-Consumer marketing of prescription drugs: Effects on prescription and over-the-counter product sales,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Law and Economics, 45:691-723, 2002.",
        "Manchanda and Chintagunta. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Responsiveness of Physician Prescription Behavior to Salesforce Effort: An Individual Level Analysis,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Marketing Letters, 15(2/3):129-145, 2004.",
        "McLachlan, G. and Peel, D., Finite Mixture Models, John Wiley and Sons:New York, 2000.",
        "Mizik, N., and Jacobson, R., \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Are Physicians \u00c3\u00a2\u00e2\u0082\u00ac\u00cb\u009cEasy Marks\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2? Quantifying the Effects of Detailing and Sampling on New Prescriptions,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Management Science, 50(12): 1704-1715, 2004.",
        "Narayanan, S., Desiraju, R., and Chintagunta, P. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Return on investment implications for pharmaceutical promotional expenditures: the role of marketing-mix interactions,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Marketing, 68(4): 90-105, 2004.",
        "Narayanan, S., Manchanda, P., and Chintagunta, P. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Temporal differences in the role of marketing communication in new product categories,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Marketing Research, 42: 278290, 2005.",
        "Nelson, P., \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Information and consumer behavior,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Political Economy, 78:311\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c329, 1970.",
        "Pew Prescription Project, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Academic Detailing: Evidence-Based Prescribing Information,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Pew Prescription Project Fact Sheet, April 2 2009.",
        "Rizzo, J., \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Advertising and Competition in the Ethical Pharmaceutical Industry: The case of Hypertensive Drugs,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Law and Economics, 42(1),89-116, 1999.",
        "SK&A. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u00932010 U.S. Pharma Company Promotion Spending,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Cegedim Strategic Data Report, http://www.skainfo.com/, January 2011.",
        "SK&A. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u00932011 U.S. Pharma Company Promotion Spending,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Cegedim Strategic Data Report, http://www.skainfo.com/, February 2012.",
        "Stigler, G.J. and Becker, G.S. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093De gustibus non est disputandum,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d American Economic Review, 67:76\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c90, 1977.",
        "Wald, A., Selke, S., Warren, T. et al. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Sexually Transmitted Diseases, 33(9): 529-533, 2006.",
        "Weiss, J., \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Medical Marketing in the United States: A Prescription for Reform,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The George Washington Law Review, 79(1): 260-292, 2010.",
        "Wooldridge J. Econometric Analysis of Cross Section and Panel Data. MIT Press: Cambridge, 2001. Wosi\u00c3\u0085\u00e2\u0080\u009eska, M. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Just what the patient ordered? Direct-to-consumer advertising and the demand for pharmaceutical products,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Harvard Business School Marketing Research Papers No. 02-04,"
    ]
}